COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,221 Articles (22,733 medRxiv, 8,488 bioRxiv)

Most recent first Previous |  Page 2030: Articles 20291-20300  | Next

Massively parallel interrogation of protein fragment secretability using SECRiFY reveals features influencing secretory system transit
Boone, M., Ramasamy, P., Zuallaert, J., Bouwmeester, R., Van Moer, B., Maddelein, D., Turan, D., Hulstraert, N., Eeckhout, H., Vandermarliere, E., Martens, L., Degroeve, S., De Neve, W., Vranken, W., Callewaert, N.
10.1101/241349 — Posted: 2020-11-26 Discussion: Onsite
Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant
Anderson, E. R., Hughes, G., Patterson, E. I.
10.1101/2020.11.25.394288 — Posted: 2020-11-26
Exploring Risks of Human Challenge Trials for COVID-19
Manheim, D., Wiecek, W., Schmit, V., Morrison, J.
10.1101/2020.11.19.20234658 — Posted: 2020-11-26
High-resolution mapping and characterization of epitopes in COVID-19 patients
Haynes, W. A., Kamath, K., Bozekowski, J., Baum-Jones, E., Campbell, M., Casanovas-Massana, A., Daugherty, P. S., Dela Cruz, C. S., Dhal, A., Farhadian, S. F., Fitzgibbons, L., Fournier, J., Jhatro, M., Jordan, G., Kessler, D., Klein, J., Lucas, C., Luchsinger, L. L., Martinez, B., Muenker, M. C., Pischel, L., Reifert, J., Sawyer, J. R., Waitz, R., Wunder, E. A., Zhang, M., Yale IMPACT Team, , Iwasaki, A., Ko, A. I., Shon, J. C.
10.1101/2020.11.23.20235002 — Posted: 2020-11-26
Diabetes and Mortality Among 1.6 Million Adult Patients Screened for SARS-CoV-2 in Mexico
Woolcott, O. O., Castilla-Bancayan, J. P.
10.1101/2020.11.25.20238345 — Posted: 2020-11-26 Discussion: Onsite
Systematic evaluation of transcriptomic disease risk and diagnostic biomarker overlap between COVID-19 and tuberculosis: a patient-level meta-analysis
Sheerin, D., Abhimanyu, A., Wang, X., Johnson, W. E., Coussens, A.
10.1101/2020.11.25.20236646 — Posted: 2020-11-26
Global analysis of protein-RNA interactions in SARS-CoV-2 infected cells reveals key regulators of infection
Kamel, W., Noerenberg, M., Cerikan, B., Chen, H., Järvelin, A. I., Kammoun, M., Lee, J., Shuai, N., Garcia-Moreno, M., Andrejeva, A., Deery, M. J., Neufeldt, C. J., Cortese, M., Knight, M. L., Lilley, K. S., Martinez, J., Davis, I., Bartenschlager, R., Mohammed, S., Castello, A.
10.1101/2020.11.25.398008 — Posted: 2020-11-25
3D8, a nucleic acid-hydrolyzing scFv, confers antiviral activity against SARS-CoV-2 and multiple coronaviruses in vitro
Lee, G., Budhathoki, S., Choi, H. S., Oh, K.-j., Lee, G.-Y., Ham, Y. K., Kim, Y. J., Lim, Y. R., Hoang, P. T., Lee, Y., Lim, S.-W., Kim, J.-M., Cho, S., Song, J.-W., Lee, S., Kim, W.-K.
10.1101/2020.11.25.398909 — Posted: 2020-11-25
SARS-CoV-2 utilizes a multipronged strategy to suppress host protein synthesis
Finkel, Y., Gluck, A., Winkler, R., Nachshon, A., Mizrahi, O., Lubelsky, Y., Zuckerman, B., Slobodin, B., Yahalom-Ronen, Y., Tamir, H., Ulitsky, I., Israely, T., Paran, N., Schwartz, M., Stern-Ginossar, N.
10.1101/2020.11.25.398578 — Posted: 2020-11-25
Evolutionary analysis of SARS-CoV-2 spike protein for its different clades
Pereson, M. J., Flichman, D., Martinez, A., Bare, P., Garcia, G., Di Lello, F.
10.1101/2020.11.24.396671 — Posted: 2020-11-25 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).